Immunohistochemical Expression of HBME-1 in a Spectrum of Thyroid Neoplasms
Introduction: Thyroid neoplasms are the most common malignancy of the endocrine system, representing 3.8% of new cancer cases, and it is the ninth most common cancer overall. The immuno-histochemical marker Hector Battifora Mesotheilial-1 (HBME-1) is a monoclonal antibody that now finds its diagnost...
Saved in:
Main Authors: | Archi A. Chawla, Reeta Dhar, Shilpi Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-10-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/ijem.ijem_451_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A study of the histopathological spectrum of thyroid neoplasms in a tertiary health care center
by: Rabia Parveen Siddiqui, et al.
Published: (2024-12-01) -
Ultrasound Findings Suggestive of Malignancy in Thyroid Nodules Classified as Follicular Lesion of Undetermined Significance or Follicular Neoplasm based on the 2017 Bethesda System for Reporting Thyroid Cytopathology
by: Heui Jin Jung, et al.
Published: (2025-01-01) -
Thermal ablation for the treatment of malignant thyroid nodules: present and future
by: Yan Hu, et al.
Published: (2024-12-01) -
A pilot study examining Toronto-area family physician perspectives on thyroid neoplasm evaluation
by: Arjun Kundra, et al.
Published: (2019-05-01) -
Diagnosis and treatment of thyroblastoma: a case report and review of literature
by: Xiting Chen, et al.
Published: (2025-02-01)